Art. 33 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 24×

Within 15 days of the receipt of the opinion, the Commission shall prepare a draft of the decision to be taken in respect of the application, taking into account Community law.

In the event of a draft decision which envisages the granting of marketing authorization, the documents referred to in Article 32(5), second subparagraph shall be annexed.

Where, exceptionally, the draft decision is not in accordance with the opinion of the Agency, the Commission shall also annex a detailed explanation of the reasons for the differences.

The draft decision shall be forwarded to the Member States and the applicantor the marketing authorisation holder.

The 10 that are cited most themselves, of 24.

  • Directive (EU) 2004/27Lawamends

  • Gesetz über den Verkehr mit Arzneimitteln25bLaw

    … (5) Bei einer abweichenden Entscheidung bezüglich der Zulassung, ihrer Aussetzung oder Rücknahme finden die Artikel 30, 32, 33 und 34 der Richtlinie 2001/83/EG Anwendung. Im Falle einer Entscheidung nach Artikel 34 der Richtlinie …

  • Geneesmiddelenwet55Law

    1. De artikelen 44, derde, vierde en vijfde lid, en 46, derde en vierde lid, van deze wet alsmede de artikelen 32, 33 en 34 van richtlijn 2001/83 zijn niet van toepassing op kruidengeneesmiddelen als bedoeld in artikel 42, achtste lid, …

  • Judgment of the Court (First Chamber) of 16 October 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DepartmenDecision

    In the course of those proceedings, the H igh Court of Justice of England and Wales, Queen’s Bench Division (Administrative Court) decided to stay the proceedings and refer the following questions to the Court for a preliminary …

    16 Oct 2008 · 62006CJ0452

  • Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…29Law

    … може да бъде подадено в съответствие с процедурата, установена в членове 32, 33 и 34 от Директива 2001/83/ЕО, когато се иска разрешително …

  • Regeling Geneesmiddelenwet3.5aLaw

    … Als de Commissie ter afsluiting van de arbitrageprocedure, bedoeld in de artikelen 32, 33 en 34 van richtlijn 2001/83, een eindbeschikking heeft vastgesteld neemt het College artikel 34, derde lid, in acht.

  • Judgment of the Court (Fourth Chamber) of 27 March 2019. Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European CommissioDecision

    In that regard, it must also be noted that, in accordance with the third paragraph of Article 33 of Directive 2001/83, only exceptional circumstances may justify the Commission in not following such an opinion.

    27 Mar 2019 · 62016CJ0680

  • Order of the Court of First Instance (Fourth Chamber) of 2 June 2004. Pfizer Ltd v Commission of the European Communities.Decision

    Article 33 of the MPHU Code provides that the Commission is to prepare a draft of the decision to be taken, taking into account Community law, within 30 days of the receipt of the opinion. Where the draft decision is not in accordance with …

    2 Jun 2004 · 62003TO0123

  • Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006. Merck Sharp & Dohme Ltd and Others v Commission of the European Decision

    Chapter 4 (‘Mutual recognition of authorisations’) of Title III HUM (‘Placing on the market’) contains the following provisions: ‘Article 27 [corresponding to Article 8 of Directive 75/319, as amended]: In order to facilitate the …

    31 Jan 2006 · 62003TJ0273

  • Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021. Pharmaceutical Works Polpharma S.A. v European MedicineDecision

    Thus, according to Article 30(1) of Directive 2001/83, if two or more applications submitted in accordance with Articles 8, 10, 10a, 10b, 10c and 11 of that directive have been made for marketing authorisation for a particular medicinal …

    5 May 2021 · 62018TJ0611